Agile governance perspective on occupational health in evolving pharmaceutical research and development models
环境与职业医学 · 2025-10 · 42 (10) · 1247-1251
DOI: 10.11836/jeom25046 ↗Kurz gefasst
Fachartikel in der Zeitschrift 环境与职业医学, 2025-10. Verfasst von Xia ZHANG und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The rapid development of the pharmaceutical research and development (R&D) has brought new challenges to occupational health management, including the high uncertainty in the R&D process, emerging hazards, and compliance complexities associated with novel business models. Traditional management approaches exhibit limitations in effectively addressing the occupational health risks associated with these challenges. Based on the perspective of agile governance, this paper proposed an optimized pathway characterized by dynamic response, adaptive flexibility, and multi-stakeholder collaboration. It further offered countermeasures and recommendations from three aspects: concept renewal, mechanism innovation, and tool empowerment, aiming to provide reference for the effective management and control of occupational health risks in the innovation and development of the pharmaceutical R&D industry.
Schlagwörter
Zitieren
APA
ZHANG, X., TANG, Y., YU, M., CHEN, J., & ZHU, S. (2025). Agile governance perspective on occupational health in evolving pharmaceutical research and development models. 环境与职业医学, 42(10), 1247-1251. https://doi.org/10.11836/jeom25046
Vancouver
ZHANG X, TANG Y, YU M, CHEN J, ZHU S. Agile governance perspective on occupational health in evolving pharmaceutical research and development models. 环境与职业医学. 2025;42(10):1247-1251. doi:10.11836/jeom25046
BibTeX
@article{ZHANG2025,
author = {ZHANG, Xia and TANG, Ying and YU, Man and CHEN, Jian and ZHU, Surong},
title = {Agile governance perspective on occupational health in evolving pharmaceutical research and development models},
journal = {环境与职业医学},
year = {2025},
volume = {42},
number = {10},
pages = {1247--1251},
doi = {10.11836/jeom25046}
}
EUVIMED